Beryl Drugs Limited

BSE: BERLDRG

BSE

21.29 1.01 (4.98%)

Prev Close

20.28

Open Price

21.29

Volume

4,913

Today Low / High

20.6 / 21.29

52 WK Low / High

17.35 / 43.7

Range

20 - 22

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 21.29, reflecting a change of 1.01 (4.98028%). The expected target range on the BSE is 20 - 22. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

30 Jun 21.29 0.00%

27 Jun 20.28 0.00%

26 Jun 19.32 0.00%

25 Jun 18.24 0.88%

24 Jun 18.82 -4.99%

23 Jun 18.82 0.00%

19 Jun 19.10 -1.47%

18 Jun 19.50 -2.05%

17 Jun 19.68 -0.91%

16 Jun 20.40 -3.53%

13 Jun 18.20 9.78%

11 Jun 19.10 0.21%

10 Jun 19.45 -2.31%

09 Jun 20.47 -4.98%

06 Jun 19.50 0.00%

05 Jun 20.15 -3.23%

04 Jun 19.20 4.95%

03 Jun 18.50 4.27%

Beryl Drugs Limited Graph

If you are looking for the target price for Beryl Drugs Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 21.29, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario	Price	Target	Range
Bullish Scenario	21.29	21.50	19.35 - 23.65
		21.72	17.37 - 26.06
		21.93	15.35 - 28.51
Bearish Scenario	21.29	21.08	18.97 - 23.18
		20.86	16.69 - 25.04
		20.65	14.46 - 26.85

ISIN

INE415H01017

Industry

Medical - Pharmaceuticals

Vol.Avg

2,068

Market Cap

107,976,493

Last Dividend

Official Website

Visit Website

IPO Date

2005-06-14

DCF Diff

N/A

DCF

Financial Ratios Every Investor Needs

Stock Rating Details for BERLDRG

Metric	Value	Recommendation
Overall Rating	C+	Sell
DCF Score	1	Strong Sell
ROE Score	4	Buy
ROA Score	4	Buy
Debt-to-Equity (DE) Score	2	Sell
Price-to-Earnings (PE) Score	1	Strong Sell
Price-to-Book (PB) Score	1	Strong Sell

Annual Financial Income Report

Date	Revenue	Co.Rev	GP	GPR	G&A Expenses	Operating Income	Net Income	EPS	EBITDA	NIR
2025-03-31	22.55 Cr	14.24 Cr	8.31 Cr	0.3686	0.00 Cr	1.40 Cr	0.58 Cr	1.14	2.64 Cr	0.0257
2024-03-31	26.45 Cr	17.77 Cr	8.68 Cr	0.3283	0.37 Cr	1.18 Cr	0.77 Cr	1.52	2.66 Cr	0.0291
2023-03-31	26.71 Cr	18.58 Cr	8.13 Cr	0.3043	0.36 Cr	1.19 Cr	0.77 Cr	1.51	2.23 Cr	0.0287
2022-03-31	14.45 Cr	10.44 Cr	4.02 Cr	0.2780	0.34 Cr	-0.65 Cr	-0.66 Cr	-1.30	0.56 Cr	-0.0456
2021-03-31	13.84 Cr	9.46 Cr	4.39 Cr	0.3168	0.44 Cr	0.20 Cr	0.24 Cr	0.47	2.07 Cr	0.0173

Annual Financials Balance Sheet

Date	C&C Equ.	Tot. Assets	Tot. Liab.	Stock. Equity	Tot. Debt	Net Debt	Inv.	PP&E (Net)	Curr. Def. Rev.	Non-Curr. Def. Rev.	LT Invest.	Curr. Liab.
2025-03-31	0.81 Cr	15.96 Cr	6.46 Cr	9.5038 Cr	4.07 Cr	3.26 Cr	1.90 Cr	6.00 Cr	0.00 Cr	0.00 Cr	0.43 Cr	4.3000 Cr
2024-03-31	0.12 Cr	17.49 Cr	8.56 Cr	8.9233 Cr	5.09 Cr	4.97 Cr	1.81 Cr	5.96 Cr	0.18 Cr	0.00 Cr	0.33 Cr	5.7554 Cr
2023-03-31	0.28 Cr	17.51 Cr	9.45 Cr	8.0664 Cr	4.54 Cr	4.26 Cr	1.05 Cr	5.81 Cr	0.13 Cr	0.11 Cr	0.37 Cr	6.3289 Cr
2022-03-31	0.27 Cr	17.82 Cr	10.53 Cr	7.2936 Cr	5.29 Cr	5.02 Cr	2.98 Cr	5.86 Cr	0.19 Cr	0.09 Cr	0.34 Cr	8.4925 Cr
2021-03-31	0.45 Cr	18.65 Cr	10.72 Cr	7.9294 Cr	5.12 Cr	4.67 Cr	2.27 Cr	7.32 Cr	0.10 Cr	0.00 Cr	0.32 Cr	8.2133 Cr

Annual Financials Cash Flow Statement

Date	Operating Cash	Investing Cash	Financing Cash	Free Cash	Cash Change	Cash at End	CapEx	Income	Debt Repay	Inventory
2025-03-31	2.1069 Cr	-0.3971 Cr	-1.0204 Cr	-0.0782 Cr	0.0000 Cr	0.8144 Cr	-2.1851 Cr	0.5789 Cr	-1.0204 Cr	-0.6426 Cr
2024-03-31	0.8202 Cr	-1.0817 Cr	0.1032 Cr	-0.5314 Cr	-0.1582 Cr	0.1249 Cr	-1.3516 Cr	1.0097 Cr	0.5668 Cr	-0.2055 Cr
2023-03-31	2.4804 Cr	-1.3017 Cr	-1.1671 Cr	0.9169 Cr	0.0117 Cr	0.2831 Cr	-1.5635 Cr	0.9839 Cr	-0.7516 Cr	1.9236 Cr
2022-03-31	-0.4688 Cr	0.5240 Cr	-0.2359 Cr	-0.8843 Cr	-0.1807 Cr	0.2714 Cr	-0.4155 Cr	-0.9503 Cr	0.0017 Cr	-0.7092 Cr
2021-03-31	0.3385 Cr	0.2550 Cr	-0.5377 Cr	-0.7144 Cr	0.0558 Cr	0.4521 Cr	-1.0529 Cr	0.3480 Cr	-0.1113 Cr	-1.1116 Cr

Quarterly Financial Income Report

Date	Revenue	Co.Rev	GP	GPR	Operating Income	Net Income	EPS	EBITDA	NIR
2025-03-31	5.22 Cr	3.73 Cr	1.49 Cr	0.2857	0.18 Cr	0.15 Cr	0.30	0.50 Cr	0.0291
2024-12-31	5.31 Cr	1.83 Cr	3.48 Cr	0.6546	0.28 Cr	0.05 Cr	0.10	0.59 Cr	0.0098
2024-09-30	5.61 Cr	2.68 Cr	2.93 Cr	0.5225	0.23 Cr	0.01 Cr	0.01	0.57 Cr	0.0012
2024-06-30	6.25 Cr	4.23 Cr	2.02 Cr	0.3230	0.67 Cr	0.37 Cr	0.73	0.99 Cr	0.0589
2024-03-31	3.21 Cr	3.83 Cr	-0.62 Cr	-0.1938	-0.29 Cr	-0.35 Cr	-0.68	0.03 Cr	-0.1082

Quarterly Financials Balance Sheet

Date	Cash & Equiv.	Short-Term Inv.	Cash & Short-Term	Net Receivables	Inventory	Total Curr. Assets	PP&E (Net)	Total Assets	Total Liabilities
2025-03-31	0.81 Cr	0.00 Cr	0.81 Cr	5.46 Cr	1.90 Cr	9.04 Cr	6.00 Cr	15.96 Cr	6.46 Cr
2024-12-31	0.00 Cr	0.00 Cr	0.18 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	-9.30 Cr
2024-09-30	0.08 Cr	0.19 Cr	0.27 Cr	0.00 Cr	1.26 Cr	8.96 Cr	7.06 Cr	17.00 Cr	7.70 Cr
2024-06-30	0.00 Cr	0.00 Cr	0.22 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	-8.92 Cr
2024-03-31	0.12 Cr	0.10 Cr	0.22 Cr	7.59 Cr	1.81 Cr	10.22 Cr	5.96 Cr	17.49 Cr	8.56 Cr

Quarterly Financials Cash Flow Statement

Date	Net Income	Operating Cash Flow	Net Cash Change	Cash at End	Cash at Beginning	Free Cash Flow
2024-12-31	0.05 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr
2024-09-30	0.01 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr
2024-06-30	0.37 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr
2024-03-31	-0.35 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr
2023-12-31	0.31 Cr	0.62 Cr	0.62 Cr	1.06 Cr	0.44 Cr	0.62 Cr

Splits History

Date	Label	Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name	Symbol	Price	Market Cap	Volume
MedPlus Health Services Limited	MEDPLUS	₹904.50	₹108,263,069,235.00	₹130,432.00

Key Executives

Chief Financial Officer

Mr. Ashish Baraskar

Gender: male

Year Born:

MD & Executive Director

Mr. Sanjay Sethi

Gender: male

Year Born: 1963

Compliance Officer & Company Secretary

Ms. Neha Sharma CS

Gender: female

Year Born:

FAQs about Beryl Drugs Limited

Who is the CEO of the company?

The CEO is Sanjay Sethi.

What is the current market price of the stock?

The current price is ₹21.29.

What is the 52-week price range?

The range is ₹17.35-43.7.

What is the market capitalization of the company?

The market capitalization is ₹10.80 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 18.79.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Beryl Drugs Limited (ISIN: INE415H01017) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹10.80 crores and an average daily volume of 2,068 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.